Inquest Clinical Research-Site Number: 8400144, Baytown
The University of Texas Southwestern Medical Center-Site Number: 8400098, Dallas
Valley Institute of Research-Site Number: 8400004, Harlingen
at 8 pa

Nagre-recruitPhase 3

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

GI Alliance - Lubbock-Site Number: 8400092, Lubbock
SMS Clinical Research-Site Number: 8400035, Mesquite
Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
at 2 pa

Nagre-recruitPhase 3

Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07184944

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
at 2 pa

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

One of a Kind Clinical Research Center - Kingwood, Kingwood
Southern Star Research Institute, San Antonio

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

One of a Kind Clinical Research Center - Kingwood, Kingwood
Southern Star Research Institute, San Antonio

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483099

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Cook Children's Medical Center, Fort Worth

Nagre-recruitPhase 3

Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04844606

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

GI Alliance - Cedar Park, Cedar Park
North Texas Gastroenterology, Denton
The University of Texas Health Science Center at Houston, Houston
at 3 pa

Nagre-recruitPhase 2

Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06226883

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Texas Digestive Disease Consultants Cedar Park, Cedar Park
GI Alliance - Digestive Health Associates of Texas, Dallas
The University of Texas Health Science Center at Houston, Houston
at 7 pa

Nagre-recruitPhase 4

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06045754

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
GI Alliance - Lubbock ( Site 0288), Lubbock
Caprock Gastro Research ( Site 0293), Lubbock
at 3 pa

Nagre-recruitPhase 3

Lahat ng edad · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06651281

Standardized Microbiota Transplant Therapy in Crohn's Disease

UT Southwestern, Dallas

Nagre-recruitPhase 2

Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06631586

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Tyler Research Institute, LLC, Tyler

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07577843

A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis

BAMC, Houston

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT04372108

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Cook Children's Medical Center, Fort Worth

Nagre-recruitPhase 3

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05509777

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

University of Texas Southwestern, Dallas
Baylor College of Medicine, Houston

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05230173

HB-adMSCs for the Treatment of Crohn's Disease

Hope Biosciences Research Foundation, Sugar Land

Nagre-recruitPhase 2

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07077746

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Southern Star Research Institute, LLC, San Antonio
Tyler Research Institute, LLC, Tyler

Nagre-recruitPhase 3

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update May 27, 2026 · NCT06227910

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

Tyler Research Institute, LLC, Tyler

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06764615

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT04751396

A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Texas Children's Hospital - Baylor - PIN, Houston

Nagre-recruitPhase 3

Edad 2 pataas · Lahat ng kasarian · Na-update May 7, 2026 · NCT05442567

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Texas Children's Hospital, Houston

Nagre-recruitPhase 3

Edad 2 hanggang 17 · Lahat ng kasarian · Na-update May 5, 2026 · NCT04779320

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Central Texas Clinical Research, LLC, Austin
Inquest Clinical Research, Baytown
Novel Research, LLC, Bellaire
at 8 pa

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06456593

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Investigational Site Number: 8400002, Fredericksburg

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, Dallas
Mirador Therapeutics Selected Site, Garland
Mirador Therapeutics Selected Site, Georgetown
at 5 pa

Nagre-recruitPhase 2

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT07113522

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Houston Methodist Hospital, Houston

Nagre-recruitPhase 4

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ene 15, 2026 · NCT06257706

Registry and Biorepository for IBD in Central Texas

Dell Medical School, UT Austin, Austin

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update May 18, 2021 · NCT04617184

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.